BMS-830216

DRUG2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Obesity

Phase 1

Safety Study to Evaluate BMS-830216 in Healthy Subjects

CompletedNCT00878020

Bristol-Myers SquibbObesity

Start: 2009-05-31End: 2009-09-30Updated: 2011-02-23

Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects

CompletedNCT00909766

Bristol-Myers SquibbObesity

Start: 2009-08-31End: 2011-06-30Updated: 2015-11-04